United States · 
Who invested in ElevateBio?
ElevateBio's investors include Redmile Group, Samsara BioCapital, UBS Oncology Impact Fund, Fidelity and Vertex Ventures, and 1 more on record.
2020202120222023
$150MSeries A$401MSeries D
United States · Series D startup
Who invested in ElevateBio
Funding summaryUpdated 26 Oct 2026
$551Mraised across 2 rounds since 2019, from 2 sources
$150MSeries A$401MSeries D
- Latest round
- Series D, $401MMay 2023
- Step-upi
- 2.7×
- Investors
- 6 (1 led)
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $150M May 2019
- Biggest round
- $401M Series D · May 2023
- Between rounds
- 4 years from the last two
The rounds
- May 2023
- May 2019Series A$150M4 new
- UBS Oncology Impact FundLead
Redmile Group
Samsara BioCapital
EcoR1 Capital
Reported by Medcitynews
Founders and team
From ElevateBio's own website: 1 founder, 7 on the team.
Ansbert GadickeCo-founder of MPM Capital
- Chris MurphyChief Executive Officer of ElevateBio
- David HallalCEO of Scholar Rock and Executive Chairman, ElevateBio
- Steven FalconeChief Operating Officer
- Vikas SinhaCFO of Scholar Rock
- Missy KotcheySVP, Head of People & Culture
- Advanced TherapiesPartner With Us
- Khalil BarrageManaging Director of The Invus Group
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Series A2019Series D2023Redmile GroupSamsara BioCapitalUBS Oncology Impact FundLFidelity
Vertex VenturesEcoR1 Capital
Redmile GroupSamsara BioCapitalUBS Oncology Impact FundLFidelityVertex VenturesEcoR1 CapitalEveryone who backed them
UBS Oncology Impact Fundno record of our own yet1round, led 1
FidelityVC firm1round
Missing a round, or an investor who was in one? Tell us.
Also claim to have backed them
This firm lists ElevateBio as a portfolio company on their own website, but no report of a round names it. They are the firms' own claims, kept apart from the rounds above.
Quick answers about ElevateBio
How much has ElevateBio raised?
ElevateBio has raised $551M across 2 rounds since 2019.
When did ElevateBio last raise?
ElevateBio's most recent round was a Series D of $401M in May 2023.
What was ElevateBio's biggest round?
Its most recent round, $401M in May 2023, is also its largest on record.
Who backed ElevateBio first?
ElevateBio's first round on record, in May 2019, was backed by UBS Oncology Impact Fund, Redmile Group and Samsara BioCapital and 1 others.
What stage is ElevateBio at?
ElevateBio's latest named round is a Series D, in May 2023.
Where is ElevateBio based?
ElevateBio is based in the United States.
Who led ElevateBio's rounds?
UBS Oncology Impact Fund led the Series A in 2019.
Companies like ElevateBio
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.